XML 32 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Activity Relating to Restricted Stock Units

The table below summarizes activity relating to restricted stock units:

 

 

 

Shares

 

Outstanding as of December 31, 2019

 

 

333,243

 

Granted

 

 

393,811

 

Vested

 

 

 

Forfeited

 

 

(22,423

)

Outstanding as of March 31, 2020

 

 

704,631

 

Summary of Stock-Based Compensation Expense Recognized

Stock-based compensation expense recognized during the three months ended March 31, 2020 and 2019 was as follows:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Research and development

 

$

12,224

 

 

$

20,745

 

Selling, general and administrative

 

 

18,886

 

 

 

23,371

 

 

 

$

31,110

 

 

$

44,116

 

Summary of Stock-Based Compensation Expense by Award Type Recognized

 

Stock-based compensation expense recognized during the three months ended March 31, 2020 and 2019 by award type was as follows:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Stock options

 

$

30,218

 

 

$

43,564

 

Restricted stock units

 

 

 

 

 

58

 

Employee stock purchase plan

 

 

892

 

 

 

494

 

 

 

$

31,110

 

 

$

44,116

 

Summary of Activity Relating to Time Based and Performance Based Stock Options

The table below summarizes activity related to time-based and performance-based stock options:

 

 

 

Shares

 

 

Weighted

Average Exercise

Price

 

 

Weighted Average

Remaining Life

(in years)

 

 

Aggregate

Intrinsic Value

(in thousands)

 

Outstanding as of December 31, 2019

 

 

8,163,113

 

 

$

106.30

 

 

 

7.75

 

 

$

87,972

 

Granted

 

 

770,860

 

 

 

68.90

 

 

 

 

 

 

 

 

 

Exercised

 

 

(7,196

)

 

 

50.99

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(314,812

)

 

 

128.21

 

 

 

 

 

 

 

 

 

Outstanding as of March 31, 2020

 

 

8,611,965

 

 

 

102.20

 

 

 

7.69

 

 

$

7,083

 

Exercisable as of March 31, 2020

 

 

4,253,664

 

 

 

85.18

 

 

 

6.63

 

 

$

7,083